Full Text (PDF)
Original Article

A Profile of bacteremia cases due to MRSA and MSSA

Akanksha Rajpoot , Akanksha Rajpoot

Author Information

Licence:




New Indian Journal of Surgery 2(4):p 214-214, October-December 2011. | DOI:

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

 Bacteremia caused by Staphylococcus aureus continues to be a common problem worldwide. Antimicrobial drug resistance in S.aureus arose early after the development of antimicrobial agents and continues to evolve. This resistance limits the potentially efficacious agents and results in frequent use of glycopeptides, such as vancomycin. The reliance on vancomycin causes difficulties because vancomycin has been shown to be less effective than isoxazolyl penicillins (e.g.,flucloxacillin) in treating severe infections caused by S.aureus. This may be one explanation for the higher death rate associated with bacteremia caused by MRSA, compared with that caused by MSSA. S. aureus remains a common cause of bloodstream infections of community onset; increasing numbers of these being caused by MRSA. Some of these infections are caused by hospital strains carried into the community by patients or healthcare workers, while others are caused by true community strains in patients who have had no recent healthcare contact. Certain population of patients have a significantly greater risk of invasive staphylococci infection than normal population; represented by those receiving hemodialysis, peritoneal dialysis, IV drug abusers, patients suffering from Diabetes Mellitus and alcohol abusers. S.aureus have developed resistance to virtually all antibiotic classes which include Aminoglycosides, Tetracyclines, Cotrimaxazole, Quinolones, and new Oxazolidinones. Methods for susceptible testing of MRSA include disk diffusion method, Broth dilution method, agar screen methods. This study helps us to have a clear knowledge about the risk factors associated with MRSA and the antibiotic sensitivity pattern of the organism which guides to formulate an empirical therapy for the patients with staphylococcal infections.


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Wednesday 29 July 2026, 20:57:04 (IST)


3354

Accesses

5
295
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share